GlobeNewswire

The FNC receives important sustainability and quality awards from the coffee industry

Dela

Rainforest Alliance, the Coffee Quality Institute (CQI) and the Specialty Coffee Association (SCA) have honored Colombian coffee growers

BOGOTÁ, Colombia, May 15, 2018 (GLOBE NEWSWIRE) -- In recent weeks, the Colombian Coffee Growers Federation (FNC) has received important sustainability and quality awards from key players in the global coffee industry such as Rainforest Alliance, the Coffee Quality Institute (CQI), and the Specialty Coffee Association (SCA).

Last week, on May 9, the FNC received one of the Rainforest Alliance Sustainable Standard-Setters Awards for its exceptional commitment to sustainability, improving coffee farmers' livelihoods, and conserving forests.

Since its creation in 1927, the FNC has worked to improve quality of life of the over 540,000 coffee-growing families it represents nowadays. "For Colombian coffee farmers, sustainability is closely linked to their raison d'être. So much so that over 236,000 coffee farms in Colombia meet some sustainability standard, and by 2027, when the FNC becomes 100 years old, we aspire to make all Colombian coffee sustainable," said the FNC CEO, Roberto Vélez, upon receiving the recognition on behalf of the Colombian coffee growers.

"The individuals, communities, and businesses we have highlighted are working to address the significant and related challenges of climate change, rural poverty, and biodiversity loss. Their work has resulted in real changes on the ground, and is helping to improve conditions for farmers and forest communities," said Han de Groot, the Rainforest Alliance CEO.

CQI 2018 Leadership Medal of Merit

On April 21 in Seattle, during its annual luncheon, the Coffee Quality Institute (CQI) awarded its 2018 Leadership Medal of Merit, in the corporate category, to the FNC, honoring its commitment of over 90 years to improving farmers' livelihoods, fostering sustainability, and increasing coffee quality, helping to strengthen the Colombian coffee sector as a whole.

"Thanks in large part to the work of the FNC, quality and sustainability are not recent trends for Colombian coffee growers," said CQI Executive Director, David Roche. "These have been a priority for over 90 years, along with differentiating quality, adding value, and staying ahead of the curve on economic, social and environmental practices."

"We receive this recognition with double gratitude: firstly, for the prestige of CQI in the global coffee industry, and secondly, because it comes at a crucial time, when we redouble efforts to increase sustainability of coffee farmers not only in Colombia, but in the world, with an approach of shared responsibility of all actors in the chain," said Vélez, the FNC CEO, on behalf of all Colombian producers.

The CQI recognized that the FNC has undertaken important initiatives and taken visionary measures to strengthen the Colombian coffee sector. The FNC's programs also help farmers prepare for challenges ahead, including adapting to climate change, fostering sustainable coffee farming, and stimulating generational continuity, the CQI highlighted.

Manos al Agua is granted SCA Sustainability Award

On April 19, also in Seattle, the Manos al Agua Project, implemented by the FNC as part of a public-private partnership, was granted the Specialty Coffee Association (SCA) Sustainability Award 2018, the most important of its kind, thanks to the results achieved in the category of Sustainable Projects.

The award was achieved thanks to the importance and results of Manos al Agua (including installation of on-farm water saving and treatment systems), as an innovative project for integrated water resources management in coffee river basins, a replicable model for sustainable rural development in Colombia.

The SCA Sustainability Award is granted since 2004 to companies and organizations that create and implement innovative projects or business models to expand and promote coffee sustainability in the world, while inspiring others to start similar initiatives.

"Manos al Agua is a holistic project, one of the most successful of the Colombian coffee institutions," Vélez, the FNC CEO, noted.

A 5-year public-private partnership, the Project started in 2013 and is made up of the FNC, the Dutch Cooperation Agency, the private companies Nestlé & Nespresso; the Colombian Coffee Research Center (Cenicafé) and the Wageningen University as scientific-academic partners, and Colombia's Presidential Agency of International Cooperation (APC-Colombia).

Contact Information:
FNC Press Office
(57+1) 3136600 Ext. 1790
martha.sanchez@cafedecolombia.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Federacion Nacional de Cafeteros de Colombia-Fondo Nacional del Café via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum